8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Oct 28, 2025 · 8mo ago · Accession 0001517022-25-000040
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Akebia Therapeutics, Inc.
- Ticker
- AKBA
- CIK
- 1517022
- Form type
- 8-K
- Filing date
- Oct 28, 2025
- Report date
- Oct 28, 2025
- Document
- akba-20251028.htm
- Size
- 205 KB